μBIOMICS

Applications of multi-omic microbiota study to the development of innovative biotechnological solutions in health 

Recent studies indicate that microbial communities play a critical role in human health. These microorganisms, collectively referred to as microbiota, participate both in the pathophysiology of different diseases and in the response of patients to pharmacological treatments. MicroBiomics (μBiomics) proposes the design, development, and implementation of a multi-omic platform and a set of bioinformatics tools.

This will allow for the characterisation, at an unprecedented level of detail and in a completely novel way, of the role of the microbiota in various pathological processes, including digestive, autoimmune, and oncological conditions. The final objective of the project is to identify bacterial communities and their activity for the design of therapeutic strategies based on biotechnology.

Thanks to the collaboration of ADItech on this project, gender has also been considered, taking into account the specific needs of both sexes, which helps achieve the project’s objective more effectively. This work has been made possible thanks to the collaboration of Irene Miguel-Aliaga, Imperial College London and the Francis Crick Institute.